September 18, 2023
Via: Pharma TimesThe updated vaccines more closely target current circulating variants The US Food and Drug Administration (FDA) has granted approval for Pfizer/BioNTech and Moderna’s updated COVID-19 vaccines, to tackle currently circulating variants. As previously recommended by the FDA, both vaccines have […]
September 18, 2023
Via: PMLiVEMillions of eligible people in England can now book their vaccine via the NHS website, the NHS app, or by calling 119 for free if they do not have access online. From this week, people aged 65 and over, pregnant […]
September 14, 2023
Via: PMLiVEThe recommendation comes after the US Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, which will be available later this week. Novavax’s protein-based updated COVID-19 vaccine is currently still under FDA review and showed promise […]
September 11, 2023
Via: Drugs.comIn a finding that should ease the minds of Americans ahead of another flu season, this year’s vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report. Even better, the flu virus […]
September 7, 2023
Via: Drugs.comNew COVID-19 booster shots could soon pass the needed hurdles for vaccinations to begin next week. Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported. The U.S. Centers […]
September 5, 2023
Via: PMLiVEFEATUREDThe investment follows the launch of the company’s new respiratory syncytial virus (RSV) vaccine, Arexvy. Designed to increase the efficiency of manufacturing processes and reduce environmental impact, the new unit will handle freeze-dried vaccines, including Arexvy, as well as the […]
August 24, 2023
Via: Biopharm InternationalRoyalty Pharma, a company specializing in acquiring pharmaceutical royalties, and Ferring Pharmaceuticals, a biopharmaceutical company with a new gene therapy expected to hit the market, announced that Royalty Pharma had acquired a synthetic royalty on US net sales of Ferring’s […]
August 22, 2023
Via: PMLiVEThe FDA’s decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD in infants from birth until they are six months old. RSV […]
August 22, 2023
Via: Drugs.comWomen may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday The vaccine is designed […]
August 14, 2023
Via: Biopharma DiveThe Food and Drug Administration has delayed by three months its decision on what could be the first vaccine available in the U.S. for chikungunya virus. In an announcement Monday, French vaccine maker Valneva said the FDA extended an evaluation […]
August 11, 2023
Via: PMLiVESchool-aged children will receive the flu vaccine either at school or at community clinics, and those who are aged two and three years or have long-term health condition will be offered the vaccine at GP surgeries. The rollout follows the […]
August 3, 2023
Via: Drugs.comWhile both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors. “The results of this study can help public health experts weigh […]
July 31, 2023
Via: PMLiVEThe modelling study, Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination, was carried out by the World Health Organization (WHO), the International Vaccine Institute, Korea (IVI) and the London School of Hygiene and Tropical […]
July 25, 2023
Via: Drugs.comMost early childhood vaccines require three or four doses for best protection, but more than 1 in 6 toddlers aren’t getting them all, leaving them vulnerable to potentially deadly infections, a new study finds. There are many reasons that kids […]
July 21, 2023
Via: Biopharma DiveAdults over the age of 60 now have two RSV vaccines to choose from in the U.S. and Europe. A new antibody treatment is available to prevent infants from infections, too. So far, Pfizer is the only drugmaker to reach […]
July 12, 2023
Via: Biopharm InternationalBiosynth announced on July 11, 2023 that it has acquired celares, a leader in the development and manufacture of conjugate vaccines and bioconjugate drugs, activated PEGs, and polymer-based drug delivery excipients, according to a company press release. The acquisition will […]
July 7, 2023
Via: Contract PharmaSanofi is partnering with Saudi drugmakers Arabio and Lifera to increase the production of vaccines in Saudi Arabia. Lifera and Sanofi signed a Memorandum of Understanding (MOU) enabling the two companies to strengthen local manufacturing. With the MOU Sanofi, LIfera […]
June 29, 2023
Via: Drugs.comAmericans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a […]
June 19, 2023
Via: PMLiVEThe Vaccines and Related Biological Products advisory committee (VRBPAC) voted 21 to zero in favour of the monovalent XBB-lineage vaccines, and generally agreed that vaccines targeting the XBB.1.5 subvariant would be preferred. XBB.1.5, which is another descendant of the Omicron […]
June 15, 2023
Via: Drugs.comAn advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken hold in […]